Profile | GDS845 / 2029 |
Title | Breast cancer cell line ME16C response to chemotherapeutics: time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM11707 | ME16C, 12h, sham | -4.031 | 2 |
GSM11716 | ME16C, 12h, sham B | 0.041 | 54 |
GSM11850 | ME16C, 24h, sham B | -0.011 | 47 |
GSM11851 | ME16C, 24h, sham | 0.166 | 62 |
GSM11721 | ME16C, 36h, sham B | 0.15 | 58 |
GSM11852 | ME16C, 36h, sham | -0.329 | 22 |
GSM11694 | ME16C, 12h, 0.5uM DOX B | -0.49 | 20 |
GSM11695 | ME16C, 12h, 0.5uM DOX | -0.173 | 37 |
GSM11734 | ME16C, 24h, 0.5uM DOX | ||
GSM11861 | ME16C, 24h, 0.5uM DOX B | -0.429 | 27 |
GSM11843 | ME16C, 36h, 0.5uM DOX | -0.478 | 25 |
GSM11862 | ME16C, 36h, 0.5uM DOX B | -0.511 | 22 |
GSM11697 | ME16C, 12h, 0.06mM 5FU | -0.063 | 47 |
GSM11714 | ME16C, 12h, 0.06mM 5FU B | -0.132 | 44 |
GSM11723 | ME16C, 24h, 0.06mM 5FU | -2.033 | 2 |
GSM11845 | ME16C, 24h, 0.06mM 5FU B | -0.633 | 21 |
GSM11683 | ME16C, 36h, 0.06mM 5FU | -0.41 | 29 |
GSM11691 | ME16C, 36h, 0.06mM 5FU B | -0.428 | 23 |